drugset / Trial / NCT00972049

Study to Assess Safety, Tolerability and Pharmacokinetics After Single Dose of AZD2516 to Japanese Healthy Subjects

NCT00972049 ↗

Phase 1 Completed 40 enrolled AstraZeneca
RandomizedParallel-groupQuadruple-blindBasic science

Summary

The primary purpose of this study is to assess the safety and tolerability of AZD2516 following administration of a single dose to Japanese healthy subjects.

Timeline

Start
2009-09
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD2516 Unknown — Oral

Indications

No indication recorded.